Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,797 | 142,998 | 159,973 | 124,482 | 65,477 |
| Marketable Securities | 675,178 | 667,715 | 548,884 | 283,586 | 278,187 |
| Receivables | 11,356 | 3,903 | 11,102 | 522 | 6,921 |
| Inventories | 6,899 | 6,290 | 8,033 | 6,121 | 4,139 |
| Other current assets | 14,773 | 15,691 | 7,518 | 8,727 | 5,415 |
| TOTAL | $837,003 | $836,597 | $735,510 | $423,438 | $360,139 |
| Non-Current Assets | |||||
| PPE Net | 90,233 | 88,958 | 86,198 | 91,084 | 96,615 |
| Intangibles | 19,316 | 17,186 | 20,089 | 25,225 | 25,295 |
| Other Non-Current Assets | 1,348 | 13,068 | 5,359 | 5,939 | 2,845 |
| TOTAL | $110,897 | $119,212 | $111,646 | $122,248 | $124,755 |
| Total Assets | $947,900 | $955,809 | $847,156 | $545,686 | $484,894 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,029 | 2,882 | 4,408 | 4,879 | 3,390 |
| Accounts payable and accrued liabilities | 28,355 | 17,984 | 11,009 | 10,239 | 8,300 |
| Accrued Expenses | 44,170 | 42,753 | 34,260 | 23,279 | 27,838 |
| TOTAL | $148,876 | $115,332 | $97,812 | $74,322 | $76,112 |
| Non-Current Liabilities | |||||
| Long Term Debt | 134,306 | 7,669 | 6,542 | 7,402 | 4,125 |
| Deferred Revenues | 67,322 | 51,713 | 48,135 | 35,925 | 36,584 |
| Other Non-Current Liabilities | 461,587 | 447,231 | 221,622 | 214,540 | 215,749 |
| TOTAL | $598,234 | $582,697 | $370,954 | $288,598 | $237,348 |
| Total Liabilities | $747,110 | $698,029 | $468,766 | $362,920 | $313,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 120,659 | 119,018 | 117,270 | 101,827 | 100,163 |
| Common Shares | 120 | 118 | 116 | 102 | 100 |
| Retained earnings | -1,094,872 | -1,006,594 | -967,610 | -906,966 | -841,488 |
| Other shareholders' equity | -13,565 | 39,747 | 21,080 | 12,480 | -770 |
| TOTAL | $200,790 | $257,780 | $378,390 | $182,766 | $171,434 |
| Total Liabilities And Equity | $947,900 | $955,809 | $847,156 | $545,686 | $484,894 |